ClinicalTrials.gg
CompletedNCT06983626azoospermiaUpdated May 25, 2025

Management of Non Obstructive Azoospermia in Men

An interventional study of micro-dissection testicular sperm extraction in Male Infertility and Azoospermia, Nonobstructive, sponsored by South Valley University. Completed at 1 site in Egypt. Open to male participants, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-25.

Primary conditionAzoospermia, NonobstructiveRegistry: Infertility, MaleReclassifiedWhy we changed it
Registry
Infertility, Male — the first condition term the registry derived for this study.
ClinicalTrials.gg
Azoospermia, Nonobstructive
Why
  1. The study's listed conditions name Azoospermia, Nonobstructive, a narrower term within Infertility, Male.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by South Valley University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 2 years 10 months after the study started (first participant enrolled Jun 2022, registered Apr 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Not applicable
Sex
Male
01

Study summary

this study predicts the factors of successful micro testicular sperm extraction in azoospermia patients in male infertility

Read the detailed description

primary outcomes: these factors were the age, testicular size, hormonal, evidence of varicocles and the out come of Micro_TESE secondary outcomes: make good decision for Micro-TESE with low economic laboratory and radiology requirement As every failed microTESE-ICSI procedure exposes the couple to an emotional, financial burden and increase the incidence of complication such as bleeding, hematoma and testicular atrophy

02

Conditions studied

  • Male Infertility
  • Azoospermia, Nonobstructive

Browse trials for

03

In context

Azoospermia, Nonobstructive Reclassified

23 studies on the registry are indexed under Azoospermia, Nonobstructive; 7 are open to participants now.

This study's enrollment of 300 is above the median of 61 across 12 interventional studies indexed under Azoospermia, Nonobstructive.

Browse Azoospermia, Nonobstructive studies →

Lead sponsor

South Valley University is the lead sponsor of 153 studies on the registry; 46 are open to participants now.

Compared within Azoospermia, Nonobstructive, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Infertility, Male. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Male
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria: Non obstructive Azoospermia with no genetic abnormalties as klinefelter syndrome

  • redo Micro TESE

Exclusion Criteria:

  • obstructive Azoospermia and bilateral congenital absent of vas
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
300 participants (actual)

Study arms

  • Active comparator
    male infertility

    azoospermia non obstructive type

    Procedure: micro-dissection testicular sperm extraction

Interventions

  • Proceduremicro-dissection testicular sperm extraction

    dissection of the seminefrous tubules under microscope to extract sperms

    Also known as: TESE, TESA, PESA

06

What researchers measure

Primary outcomes

  1. Sperm Retrieval Success Rate and identification of Predictive Factors

    Determine which preoperative factors are significantly associated with successful sperm retrieval. These may include: Serum Follicle-Stimulating Hormone (FSH) Levels: Elevated FSH levels have been linked to reduced sperm retrieval success. And patient Age and testicular size to reach the best one to predict the success rate

    Time frame: 1st 1 year

Secondary outcomes

  1. Assess the success rates of ART procedures following sperm retrieval and complications

    Assisted Reproductive Technology (ART) Outcomes Fertilization Rates: The percentage of oocytes successfully fertilized. Embryo Development: Quality and progression of embryos to the blastocyst stage. Clinical Pregnancy Rates: Confirmed pregnancies via ultrasound. Live Birth Rates: The ultimate success metric of ART procedures Complication Rates Monitor and document any complications arising from the sperm retrieval procedure, such as: Testicular Hematoma Infection Testicular Atrophy

    Time frame: 2 years

07

Study locations

1 site
  • Faculty of Medicine, South Valley University
    Luxor, Qena 83511, Egypt
08

References and documents

Related links

Individual participant data

Plan to share: Yes — according to the results

Supporting information: Study protocol

Time frame: 2 years

Access criteria: urologist and andrologist

Data sharing details ↗ · svuijm.journals.ekb.eg

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jun 2022 to primary completion in Apr 2024, 22 months.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 28, 2025
First posted
May 21, 2025
StartActual
Jun 1, 2022
Primary completionActual
Apr 1, 2024
CompletionActual
Apr 1, 2025
Last update
May 25, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 25, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06983626
Responsible party
Hafez Badawy Hafez (assistant lecturer of urology, South Valley University) — Principal investigator
First posted
May 21, 2025
Start date
Jun 1, 2022
Primary completion
Apr 1, 2024
Completion
Apr 1, 2025
Last update
May 25, 2025

Study contacts

Gamal abdelhammid alsagheer, professour of urology, professour
study director · South Valley University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion